Print this page    •   Back to Web version of article

Anti-HIV Drug Identification Chart

January 2005

Generic Name Brand Name Abbreviation Pharmaceutical Co.
Nucleoside Analog Reverse Transcriptase Inhibitors (NRTIs) & Nucleotide Analog Reverse Transcriptase Inhibitors (NtRTIs)
abacavir Ziagen ABV GlaxoSmithKline
didanosine Videx ddI Bristol-Myers Squibb
didanosine enteric-coated Videx EC ddI EC Bristol-Myers Squibb
emtricitabine Emtriva FTC Gilead
emtricitabine + tenofovir Truvada   Gilead
lamivudine Epivir 3TC GlaxoSmithKline
lamivudine + zidovudine Combivir CBV (3TC + AZT) GlaxoSmithKline
lamivudine + abacavir + zidovudine Trizivir TZV (3TC + ABV + AZT) GlaxoSmithKline
stavudine Zerit d4T Bristol-Myers Squibb
stavudine extended release Zerit XR d4T XR Bristol-Myers Squibb
tenofovir Viread TNV Gilead
zalcitabine Hivid ddC Hoffman La Roche
zidovudine Retrovir AZT or ZDV GlaxoSmithKline
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdine Rescriptor DLV Agouron
efavirenz Sustiva EFV Bristol-Myers Squibb
nevirapine Viramune NVP Boehringer Ingelheim
Protease Inhibitors (PIs)
amprenavir Agenerase APV GlaxoSmithKline
atazanavir Reyataz ATV Bristol-Myers Squibb
fosamprenavir Lexiva FPV GlaxoSmithKline
indinavir Crixivan IDV Merck
lopinavir + ritonavir Kaletra LPV Abbott Laboratories
nelfinavir Viracept NFV Agouron
ritonavir Norvir RTV Abbott Laboratories
saquinavir
(Hard Gel Cap)
Invirase SQV (HGC) Hoffman La Roche
saquinavir
(Soft Gel Cap)
Fortovase SQV (SGC) Hoffman La Roche
Entry Inhibitors
enfuvirtide Fuzeon T20 Roche/Trimeris




This article was provided by Project Inform. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art5006.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.